OR WAIT null SECS
Healthmark Industries Co., Inc. announces that Mary Ann Drosnock, MS, CIC, CFER, RM (NRCM) is now the company's manager of clinical education, specializing in GI endoscopy.
“We are very pleased to welcome Mary Ann to Healthmark Industries,” says Healthmark vice president Ralph Basile. “Her expert knowledge and experience in the GI field will play a vital role in the development of our GI product line and providing guidance and support to our GI customers.”
Drosnock comes to Healthmark Industries with extensive experience in the Healthcare Industry. Most recently, Drosnock was responsible for management of the infection control program and device reprocessing functions for Olympus America, including Canada and Latin America. In this role, she had responsibility for the development of position statements and policies regarding device compatibility, and health and safety information related to device utilization and reprocessing.
Earlier in her career, Drosnock worked for nine years in the pharmaceutical industry in a supervisory capacity as a microbiologist in both quality control and research and development. Immediately following this role, she moved on to be an adjunct professor of Microbiology at a local college.
In 1999 Drosnock received a bacherlor's degree in biology from Albright College in Reading, Pa., and in 2006 she received a master of science degree in medical device and pharmaceutical quality assurance and regulatory affairs from Temple University in Philadelphia. She has also obtained certifications in both drug development and pharmaceutical science from Temple University. In 2011, she received her certification in infection control through APIC and the Certification Board of Infection Control (CBIC). In 2012, Drosnock received her certification as a flexible endoscope reprocessor (CFER) through the Certification Board of Sterile Processing (CBSPD). Additionally, as of 2013 she attained the status of nationally certified registered microbiologist (RM [NCRM]) through the American Society for Microbiology (ASM).
Drosnock is an active member of AAMI’s Sterilization Standards Committee, including the co-chair of WG84, the work group responsible for the recently published ST91, endoscope reprocessing document.
Source: Healthmark Industries Co., Inc.